Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease - case report.
Oligodendrocyte prosaposin restores subarachnoid haemorrhage-induced consciousness impairment.
RETRACTED: Dal Monte et al. Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis. 2018, , 325.
Loss of Thyroid Hormone Transporters MCT8 and OATP1C1 in Mouse Oligodendroglia Cells Results in a Delayed Oligodendrocyte Maturation and Myelination.
Reliability and validity of the psychomotor vigilance task to quantify cognitive fatigability in multiple sclerosis.
Fatigue in Neurological Rehabilitation: Why Brain Diversity and Population Diversity Matter.
Multiple sclerosis and housing insecurity or forcible displacement: A scoping review.
Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.
Jump assessment on a force plate-an approach to quantify subtle lower limb neuromuscular deficits in people with multiple sclerosis.
Translational stem cell therapy for neurodegeneration and CNS trauma: a focused review.
Toward a definition of a core outcome set in neuromyelitis optica spectrum disorder: a scoping review protocol.
Human Herpesvirus-6A and -6B (HHV-6A and HHV-6B): The Role of Roseoloviruses in Neurological Dysfunction and the Mechanisms of Viral-Induced Epileptogenesis.
Current perspectives on the pathogenesis of multiple sclerosis: A minireview.
Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
Invasive sino-orbital aspergillosis with intracranial extension: a multidisciplinary and ethical dilemma in pursuing aggressive surgery versus palliation.
Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors.
Systemic lupus erythematosus complicated by hydrocephalus and neuromyelitis optica spectrum disorder presenting with complex neuropsychiatric manifestations: a case report.
A Case of Optic Neuritis with Glial Fibrillary Acidic Protein Antibody and Secondary Ophthalmoplegia.
Spinal cord microglia exhibit a dysfunctional response to myelin damage.
Relationship trust in individuals with multiple sclerosis: a network analysis approach.
Myelin Alteration in Neurodevelopmental Disorders: Integrating Clinical and Preclinical Evidence.
Neuroglia Alterations in the Olfactory Bulbs in Patients with Schizophrenia: An Exploratory Postmortem Study.
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years.
Therapeutic reactivation of hippocampal progenitors reverse cognition decline in mice with progressive brain demyelination.
Pages
« first
‹ previous
…
983
984
985
986
987
988
989
990
991
…
next ›
last »